Entero Therapeutics, Inc. (NASDAQ:ENTO – Get Free Report) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 96,000 shares, a drop of 31.3% from the February 13th total of 139,800 shares. Currently, 2.1% of the shares of the stock are sold short. Based on an average daily volume of 309,400 shares, the short-interest ratio is presently 0.3 days.
Entero Therapeutics Stock Up 2.1 %
ENTO opened at $0.48 on Friday. Entero Therapeutics has a 52-week low of $0.19 and a 52-week high of $3.16. The firm’s fifty day simple moving average is $0.53 and its two-hundred day simple moving average is $0.52.
About Entero Therapeutics
Read More
- Five stocks we like better than Entero Therapeutics
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- The 3 Best Blue-Chip Stocks to Buy Now
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Entero Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entero Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.